Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.36 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1713065 | 0.77 | GLRA1 (0.38) | CYP1A2KMT2ATHRBCTHEGLN1 | |
| SCHEMBL11282782 | 0.76 | ALDH1A1 (0.42) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL28107711 | 0.75 | MEN1 (0.36) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL28807752 | 0.74 | PLA2G2A (0.44) | ALDH1A1MEN1KMT2ASLC22A6SLC22A8 | |
| SCHEMBL14420949 | 0.74 | FFAR3 (0.40) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL28738431 | 0.74 | — | — | |
| SCHEMBL1407278 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL5073983 | 0.73 | PLA2G2A (0.43) | ALDH1A1MEN1KMT2ASLC22A6SLC22A8 | |
| Hydrochloric Acid SCHEMBL1115261 | 0.73 | PLA2G2A (0.43) | ALDH1A1MEN1KMT2ASLC22A6SLC22A8 | |
| Hydrochloric Acid SCHEMBL2310467 | 0.72 | KDM4E (0.41) | ALDH1A1MEN1CYP1A2KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234517-A | Bicyclic peptide ligand drug conjugates | 拜斯科阿迪有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118215505-A | Bicyclic peptide ligand drug conjugates | 拜斯科技术开发有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118234517-A | Bicyclic peptide ligand drug conjugates | 拜斯科阿迪有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118215505-A | Bicyclic peptide ligand drug conjugates | 拜斯科技术开发有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-9012603-B2 | Peptides that block the binding of IgG to FcRn | BIOGEN IDEC HEMOPHILIA INC. (US) | 2015-04-21 | — | — | US | disclosed |
| US-8906844-B2 | Immunomodulatory peptides | BIOGEN IDEC HEMOPHILIA INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-8101186-B2 | Peptides that block the binding of IgG to FcRn | SYNTONIX PHARMACEUTICALS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20110230639-A1 | IMMUNOMODULATORY PEPTIDES | SYNTONIX PHARMACEUTICALS INC. (US) | 2011-09-22 | — | — | US | disclosed |
| US-20110059889-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn | SYNTONIX PHARMACEUTICALS, INC. | 2011-03-10 | — | — | US | disclosed |
| EP-2203471-A2 | IMMUNOMODULATORY PEPTIDES | SYNTONIX PHARMACEUTICALS, INC. (US) | 2010-07-07 | — | — | EP | disclosed |
| CN-101421297-A | Peptides that block the binding of igg to fcrn | SYNTONIX PHARMACEUTICALS INC (US) | 2009-04-29 | — | — | CN | disclosed |
| WO-2009020867-A2 | IMMUNOMODULATORY PEPTIDES | SYNTONIX PHARMACEUTICALS, INC. (US) | 2009-02-12 | — | — | WO | disclosed |
| EP-1991572-A2 | PEPTIDES THAT BLOCK THE BINDING OF IGG TO FCRN | SYNTONIX PHARMACEUTICALS, INC. (US) | 2008-11-19 | — | — | EP | disclosed |
| US-20070254831-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn | BIOGEN HEMOPHILIA INC. | 2007-11-01 | — | — | US | disclosed |
| WO-2007098420-A2 | PEPTIDES THAT BLOCK THE BINDING OF IGG TO FCRN | SYNTONIX PHARMACEUTICALS, INC. (US) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059889-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn | FCGRT, FCGR3B, FCGR1A | ALDH1A1 4835/4885MEN1 2366/4885CYP1A2 4660/4885 |
| US-20070254831-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn | FCGRT, FCGR3B, FCGR1A | ALDH1A1 4835/4885MEN1 2366/4885CYP1A2 4660/4885 |
| US-20110230639-A1 | IMMUNOMODULATORY PEPTIDES | FCGRT, FCGR3B, FCGR2A | ALDH1A1 4501/4885MEN1 2138/4885CYP1A2 4799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.